Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01730092 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 334 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Re-verified, no change to tracked fields
  3. Minor Re-verified, no change to tracked fields
  4. Minor Study description revised
    • Eligibility criteria expanded, about 4 words
  5. Minor 9 versions Re-verified since Jun 2, 2026, no change to tracked fieldsv322-v330
Show 37 earlier versionsHide 37 earlier versions
  1. Minor Study description shortened, about 14 wordsv321
  2. Minor 14 versions Re-verified since Feb 19, 2026, no change to tracked fieldsv307-v320
  3. Minor Study Status, Study Description, Arms and Interventionsv306
  4. Minor 21 versions Re-verified since Aug 26, 2025, no change to tracked fieldsv285-v305
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: \- High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a rare disorder. Some people have disease-associated PAH and some have PAH from an unknown cause. Researchers want to follow the natural history of all PAH patients to understand how PAH progresses in order to discover targets for future research into new treatments. To further identify treatment targets, they will compare healthy volunteers to patients with PAH. Objectives: \- To study the natural history of PAH. Eligibility: * Individuals at least 18 years of age who have PAH. * Healthy volunteers at least 18 years of age. Design: * Participants with PAH will have periodic visits to the National Institutes of Health Clinical Center. After the first visit, they will return in 6 months and then yearly or every other year for as long as the study continues. * The first visit will take up to 3 days. It will involve the following tests: * Physical exam and medical history * Blood and urine samples * Heart and lung function tests and imaging studies * Six-minute walk test * Questions about exercise and physical activity * Healthy volunteers will have only one visit to the Clinical Center, during which they will undergo screening tests, and complete many of the same tests as patients with PAH
Trial Details
NCT Number NCT01730092
Lead Sponsor National Institutes of Health Clinical Center (CC)
Conditions
(from sponsor)
Pulmonary Disease, Pulmonary Hypertension
Related terms Hypertension, Pulmonary, Lung Diseases
Enrollment 270 participants
Start Date
Primary Completion (estimated)
Updated on ClinicalTrials.gov